Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from CardieX ( (AU:CDX) ) is now available.
CardieX Limited has announced an investor webinar scheduled for June 13, 2025, to be hosted by CEO Craig Cooper, along with other key executives. The webinar will provide updates on the company’s business operations, product developments, sales, and overall activities, potentially impacting its market positioning and stakeholder interests.
More about CardieX
CardieX is a company focused on advancing medical technology to enhance vascular health and longevity. It offers a range of products including medical and home health devices, as well as digital solutions targeting hypertension, cardiovascular disease, and other vascular health disorders. These products are based on the company’s leading SphygmoCor® vascular biomarker technology. CardieX is publicly traded on the Australian Stock Exchange under the ticker ASX:CDX.
Average Trading Volume: 247,732
Technical Sentiment Signal: Sell
Current Market Cap: A$21.45M
Find detailed analytics on CDX stock on TipRanks’ Stock Analysis page.